Dr. Joseph Fair: American Virologist Fighting Ebola in the DRC Talks Challenges, Setbacks
In part 2 of our Q&A with Fair, we talk about the challenges ahead in the fight against Ebola in the Democratic Republic of the Congo.
FDA Expands Approval for Glecaprevir and Pibrentasvir
The FDA has approved treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis that shortens duration of treatment to 8 weeks.
Dr. Joseph Fair: From the Lab to the Field, 'Virus Hunter' Battles Ebola in the DRC
In part 1 of our Q&A with Fair, we talk about his background, education, and experience, and also how the outbreak response to the current Ebola outbreak in the DRC differs from traditional disaster response.
Efforts to Reduce Nosocomial Ebola Transmission in the DRC
In this outbreak, 18% of Ebola cases have been tied to health care transmission. How can we prevent this from continuing?
FDA Accepts Biologic License Application for Merck's Ebola Vaccine
The target action date for the V920 investigational Ebola vaccine is set for March 14, 2020.
32 Hepatitis A Outbreaks Linked to Drinking Water Identified From 1971-2017
Although drinking water-associated outbreaks are rarely reported in the United States, they were the most commonly reported etiology for outbreaks associated with untreated ground water from 1971-2008.
Ebola Survivors Experience Increased Mortality Risk in Year Following Recovery
Investigators observed that, when compared with the general population of Guinea, survivors of Ebola had a 5-fold increased risk of mortality over a mean of 1 year of follow-up after discharge.
FDA Activity Tracker: Top Approvals of 2019 to Date
As the summer comes to a close, our editorial team is looking back at the top FDA approvals of 2019 to date and looking ahead at what is left on the docket this year.
Hepatitis A Outbreaks Spotlight Importance of Vaccinations, Risk-Factor Awareness
No one knows exactly why thousands of patients in dozens of states have contracted hepatitis A in recent years. In the absence of an explanation, public health officials are focusing on vaccination.
HHS Funding Backs Additional Year of Ebola Vaccine Manufacturing
The Biomedical Advanced Research and Development Authority will contribute $23 million for Merck to continue manufacturing the Ebola vaccine over the next year.
New Study Explores Link Between Hepatitis C and Atherosclerotic Cardiovascular Disease
A team of investigators review global HCV infection rates in an attempt to quantify HCV-associated cardiovascular disease.
Data Collection Gaps Are Damning the Ebola Outbreak
Variances in collection and siloed efforts are hurting this outbreak response.
Could an Already FDA-Approved Drug Be the Key to Treating Ebola?
The research team deciphered that the nitazoxanide boosts the ability of specific viral sensors to detect Ebola when infected, which then sparks an antiviral immune response.
Ebola Clinical Trial Halted in DRC
An independent monitoring board recommended early termination of the PALM trial after determining that 2 of the 4 experimental therapies were linked with better rates of survival.
Ebola Vaccine Trial Launches in Uganda
The Ad26.ZEBOV, MVA-BN-Filo vaccine regimen will be evaluated in an open-label, single-arm study of 800 participants, including frontline health care workers.
Florida Declares Public Health Emergency in Response to Hepatitis A Outbreak
The state has documented 2582 cases of hepatitis A in the ongoing outbreak. Health officials indicate that 98% of those cases were acquired within the state.
Universal Hepatitis B Screenings for Pregnant Women Included in New Recommendations
The new recommendations aim to limit the potentially deadly disease from infecting newborns or mothers.
One Year of Ebola in DRC: What Makes the North Kivu Province Outbreak Distinct?
August 1, 2019, marks the 1 year anniversary of the North Kivu Ebola outbreak.
The Complexities of the DRC Ebola Outbreak
From vaccines to conflict, here's an update on why this Ebola outbreak is so unique.
Ebola Outbreak Declared Public Health Emergency of International Concern
Dr. Tedros has accepted the World Health Organization (WHO) International Health Regulations Emergency Committee's recommendation.
Ebola Case Confirmed in DRC City Bordering Rwanda
The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.
Arizona's Roadmap to Containing a Hepatitis A Outbreak
Facing an outbreak of HAV, Arizona works to collaborate across public health departments and health care facilities.
ACIP Updates Hepatitis A Vaccine Recommendations
The recommendations are currently under review by US Centers for Disease Control and Prevention and the Department of Health and Human Services.
Determining Ebola PPE: A Guide to Avoid Occupational Exposures
A new matrix will help prepare multiple industries to combat potential Ebola occupational exposures
Uganda Authorizes Use of 3 Experimental Ebola Therapeutics
The neighboring nation to the DRC has also launched ring vaccination following the confirmation of 3 travel-associated Ebola cases.
Ebola Cases Confirmed in Uganda
This case is the first confirmed case of Ebola that Uganda has detected during the ongoing outbreak in the neighboring Democratic Republic of the Congo.
DRC Ebola Outbreak Tops 2000 Cases
As the DRC records 2000 cases of Ebola, Contagion® spoke with Krutika Kuppalli, MD, about how this outbreak is unique and whether there is an end in sight.
WHO: Meeting Global Goals for HIV, Hepatitis, STIs Requires Accelerated Effort
Meeting goals to eliminate HIV, viral hepatitis, and sexually transmitted infections by 2030 will require accelerated efforts, according to a progress report from the WHO.
Ohio Increases Funding to Fight Hepatitis A Outbreak
The state will allocate an additional $650,000 that will be divided up amongst areas of need.
HCV Testing and Treatment in Prisons Improves Outcomes, But At What Price?
Initiating a model that provides testing, treatment and linkage to care for HCV in correctional facilities would improve outcomes but requires a costly investment.
2 Clarke Drive Cranbury, NJ 08512